Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, openlabel, phase 3 randomised controlled trial - Powles, T; Durán, I; van der Heijden, M S (Lancet, 2017)
et al.